Dova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET® (avatrombopag)
DOVA PHARMACEUTICALS (DOVA)
Last dova pharmaceuticals earnings: 11/12 06:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dova.com/investor-relations
Company Research
Source: GlobeNewswire
DURHAM, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the U.S. Food and Drug Administration (FDA) has completed their Priority Review and approved DOPTELET® (avatrombopag) for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure; this represents the first thrombopoietin (TPO) receptor agonist approved in the United States for this indication. The DOPTELET label reflects the consistent safety and efficacy data from two global, multicenter, randomized, double-blind, placebo-controlled Phase 3 trials that met all primary and secondary endpoints, and supported the approval of DOPTELET. “We are delighted FDA has approved DOPTELET, which represents a significant milestone for Dova, physicians, and most importantly, patients,” said Alex C. Sapir, President and Chief Executive Officer. “DOPTELET is the first orally administered treatment option for patients with CLD, a
Show less
Read more
Impact Snapshot
Event Time:
DOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOVA alerts
High impacting DOVA PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics